FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
"I have been using BLC with Cysview for both TURBT's and surveillance. I am looking forward to sharing my experience. Using these new techniques more broadly should result in improved patient outcomes," said Dr. James McKiernan, John K Lattimer Professor and Chairman of Urology at Columbia University and Urologist-in-Chief New York Presbyterian Hospital New York.Photocure is also unveiling the company's strategic focus, exhibiting as The Bladder Cancer Company. "In this, the Bladder Cancer Awareness month, we are excited to announce our continued focus on bladder cancer and look forward to working with the bladder cancer community to increase awareness of Bladder Cancer and our breakthrough technology, BLC with Cysview," says Kjetil Hestdal, MD, PhD, President and CEO, Photocure ASA.
Key Activities featuring Cysview during the meeting include:
May 18, 2018 (Friday) 9:30 AM to 11:30AM – Location: MCC WEST, 3006
- Blue Light Cystoscopy Improves Detection Rates: Updated Results From A Prospective Multicenter RegistryHow is outpatient blue light cystoscopy used in clinical routine? First results from the Nordic registryThe impact of Blue Light Cystoscopy on the response of induction BCG in patients with high-grade non-muscle invasive bladder cancer
- Assessment of Blue Light Flexible Cystoscopy with Cysview on Patient Reported Outcomes– by Dr. Angela Smith, University of North Carolina
- Blue light in combination with Cysview Leads to Bladder Cancer Cell Death in an in vitro Mode
- Surgical Techniques: Tips & Tricks: Bladder Cancer: Moderator: Dr. Kristen Scarpato – Vanderbilt University with other Panel Members: Dr. Joe Liao – VA Palo Alto and Dr. Bernie Bochner including: Dr. James McKiernan, New York Presbyterian, Columbia University, who will present on Enhanced Cystoscopy – BLC – TURBT + Surveillance Video plus moderated presentation
Complete AUA 2018 Coverage
FDA Approval of New Indications for Blue Light Cystoscopy with Cysview®
TURBT More Important Than Ever